Measuring the uncertainties of pandemic influenza

July 2, 2012

A major collaboration between US research centers has highlighted three factors that could ultimately determine whether an outbreak of influenza becomes a serious epidemic that threatens national health. The research suggests that the numbers in current response plans could be out by a factor of two or more depending on the characteristics of the particular pandemic influenza.

Researchers from Argonne, Los Alamos, and Sandia National Laboratories, and the National Renewable Energy Laboratory, have used sensitivity analysis to uncover the most important disease characteristics pertaining to the spread of infection with an . These are: the fraction of the transmission that occurs prior to symptoms, the reproductive number, and the length of each disease stage. Their use of data from past pandemics as well as information on potential viral evolution demonstrates that current response planning may underestimate the pandemic consequences significantly.

"It has become critical to assess the potential range of consequences of a outbreak given the uncertainty about its disease characteristics while investigating risks and of vaccines, antiviral drugs, and social distancing measures," explains Jeanne Fair of Los Alamos National Laboratory and her colleagues. The team has used a and rigorous experimental design with sensitivity analysis to show the extremes of consequences of a potential pandemic outbreak in the USA. The simulation incorporates uncertainty in the evolution and characteristics of the pathogen and differences in the epidemic response, and uncertainties in the sociological response to a pandemic.

Although we are yet to face an H5N1 avian , the team suggests that they have nevertheless been able to develop a worst-case scenario for all possibilities considering mortality rates and infectiousness based on current knowledge and historical patterns dating back to the 1917-1918 . They suggest that a future worst-case influenza pandemic might be up to four times as lethal as the pandemic that occurred towards the end of the Great War. Moreover, their simulation suggests that the use of antiviral drugs may not be as effective as healthcare authorities would hope. On a positive note, they have found that social distancing could be the most effective way to contain the spread of infection, usefully reducing symptoms by an average of 16% although it will cost 50% more than antiviral use through lost working days and commerce.

"Do we prepare for the worst-case scenario when preparing for a pandemic?" asks Fair. "While the worst-case scenario is indeed the worst, it may not be as likely. As far as , the 1918 was the worst but really still was only around 2% which is could be considered low." While, the next pandemic could be worse than that of 1917-1918, the may not be as likely, the team concludes. Their study supports earlier findings that no single, pure strategy is best and that a mix of pharmaceutical and non-pharmaceutical interventions will be needed to contain the disease and reduce the total number of deaths. It would be prudent to incorporate these findings in planning for the next pandemic, the team asserts.

Explore further: Earliest known evidence of 1918 influenza pandemic found

More information: "Measuring the uncertainties of pandemic influenza" in Int. J. Risk Assessment and Management, 2012, 16, 1-27

Related Stories

Earliest known evidence of 1918 influenza pandemic found

September 19, 2011
Examination of lung tissue and other autopsy material from 68 American soldiers who died of respiratory infections in 1918 has revealed that the influenza virus that eventually killed 50 million people worldwide was circulating ...

New light shed on world’s deadliest pandemic mystery

November 15, 2011
University of Queensland research into the world's most deadly influenza pandemic in 1918 has shed light on a major medical mystery.

Recommended for you

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

Mind-body therapies immediately reduce unmanageable pain in hospital patients

July 25, 2017
Mindfulness training and hypnotic suggestion significantly reduced acute pain experienced by hospital patients, according to a new study published in the Journal of General Internal Medicine.

Research examines lung cell turnover as risk factor and target for treatment of influenza pneumonia

July 24, 2017
Influenza is a recurring global health threat that, according to the World Health Organization, is responsible for as many as 500,000 deaths every year, most due to influenza pneumonia, or viral pneumonia. Infection with ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.